Back
Day Range
$3.13
$3.29
52-Week Range
$3.13
$11.85
Volume
344,860
50D / 200D Avg
$4.53
/
$6.85
Prev Close
$3.13
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.2 | 0.2 |
| P/B | — | 3.0 |
| ROE % | — | 3.6 |
| Net Margin % | -47.4 | 3.8 |
| Rev Growth 5Y % | 64.7 | 9.9 |
| D/E | — | 0.2 |
Analyst Price Target
Hold
$8.60
+173.9%
Low: $5.00
High: $10.00
Forward P/E
34.93
Forward EPS
$0.09
EPS Growth (est.)
+0.0%
Est. Revenue
643.13M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.08
$1.62 – $2.49
|
1.75B | 1 |
| FY2029 |
$1.17
$0.91 – $1.40
|
1.39B | 1 |
| FY2028 |
$0.56
$0.15 – $0.97
|
1.04B | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-18 | -$0.01 | -$0.37 | -6334.8% |
| 2025-11-12 | $0.05 | -$0.02 | -140.0% |
| 2025-08-13 | -$0.26 | $0.14 | +153.8% |
| 2025-05-07 | -$0.17 | $0.35 | +305.9% |
| 2025-03-26 | -$0.39 | -$0.24 | +38.5% |
| 2024-11-13 | -$0.06 | $0.19 | +401.6% |
| 2024-08-15 | -$0.28 | $0.28 | +200.0% |
| 2024-05-21 | -$0.08 | -$0.89 | -972.3% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 64.66% annually over 5 years — strong growth
Negative free cash flow of -293.84M
PEG of 0.24 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 370.90%
Interest coverage of 0.44× — tight debt servicing
Growth
Revenue Growth (5Y)
64.66%
Revenue (1Y)435.56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC6.72%
Net Margin-47.35%
Op. Margin14.22%
Safety
Debt / Equity
N/A
Current Ratio2.35
Interest Coverage0.44
Valuation
P/E Ratio
-4.22
Forward P/E34.93
P/B RatioN/A
EV/EBITDA30.40
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 435.56% | Revenue Growth (3Y) | 142.85% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 64.66% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 489.68M | Net Income (TTM) | -231.86M |
| ROE | N/A | ROA | -18.98% |
| Gross Margin | 62.16% | Operating Margin | 14.22% |
| Net Margin | -47.35% | Free Cash Flow (TTM) | -293.84M |
| ROIC | 6.72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.35 |
| Interest Coverage | 0.44 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4.22 | Forward P/E | 34.93 |
| P/B Ratio | N/A | P/S Ratio | 2.00 |
| PEG Ratio | 0.24 | Forward PEG | N/A |
| EV/EBITDA | 30.40 | Fwd EV/EBITDA | N/A |
| Forward P/S | 1.52 | Fwd Earnings Yield | 2.86% |
| FCF Yield | -30.03% | ||
| Market Cap | 978.43M | Enterprise Value | 2.12B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 489.68M | 91.43M | 83.03M | 36.77M | 66.62M |
| Net Income | -231.86M | -551.73M | -513.58M | -101.50M | -170.04M |
| EPS (Diluted) | -0.87 | -2.43 | -2.60 | -3.25 | -5.44 |
| Gross Profit | 304.37M | -69.42M | 18.93M | 36.77M | 66.62M |
| Operating Income | 69.64M | -354.86M | -346.44M | -235.46M | -137.54M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1.22B | 950.09M | 828.44M | 597.98M | 474.42M |
| Total Liabilities | 1.63B | 1.88B | 1.39B | 733.59M | 1.34B |
| Shareholders' Equity | -412.77M | -932.49M | -564.42M | -135.61M | -867.24M |
| Total Debt | 1.19B | 1.08B | 805.10M | 523.05M | 676.85M |
| Cash & Equivalents | 51.43M | 11.16M | 66.43M | 17.56M | 31.69M |
| Current Assets | 455.02M | 194.84M | 230.74M | 119.82M | 86.16M |
| Current Liabilities | 193.40M | 260.95M | 167.29M | 111.84M | 50.98M |